1st Annual Mount Sinai MASLD/MASH (NAFLD/NASH) Center of Excellence Symposium – Part 1

MASLD/MASH (NAFLD/NASH) - New Nomenclature, Risk Stratification, and Therapeutics on the HorizonПодробнее

Pathogenesis and Treatment of Hepatic Fibrosis: Is reversal of Cirrhosis a Myth? by Meena Bansal, MDПодробнее

NAFLD/NASH Present & Future Management OptionsПодробнее

Fatty Liver Disease.Obesity.NASH.NAFLD.Dr.Patric Basu. P-1Подробнее

01: MASLD - The New NAFLD Nomenclature?Подробнее

Conference about NASH disease in New York City - International NASH Day 2019Подробнее

Part I - Fatty Liver Foundation DevelopmentПодробнее

NAFLD is now MASLD: What’s New in 2023Подробнее

Breaking Down NAFLD: New Guidance for Diagnosis and TreatmentПодробнее

The Division of Liver Diseases at Mount Sinai -- A Unique TeamПодробнее

Fatty Liver Disease Webinar - July 2021Подробнее

HealthTalks - Nonalcoholic Steatohepatitis (NASH) in Madisonville, KentuckyПодробнее

50th Anniversary: Dr. Scott Friedman's StoryПодробнее

Novel candidate drug targets for non-alcoholic fatty liver disease identifiedПодробнее

Dr. Scott Friedman - DDW 2021Подробнее

Obesity: The Leading Cause of NAFLD and the Most Urgent Threat to Public Health TodayПодробнее

NAFLD/NASH Policies and Practice in Sub-Saharan Africa | Jeffrey Lazarus, PhD, MIH, MAПодробнее